{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:04:43Z","timestamp":1790100283363,"version":"4.0.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["228187"],"award-info":[{"award-number":["228187"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Measles control efforts have been implemented over the years. However, elimination of the disease is yet to be realized. Additionally, global measles vaccination coverage has stagnated over the past decade, leading to outbreaks. We assessed the cost-effectiveness and budget impact of scaling-up vaccination coverage in Kenya, towards the measles elimination goal. A cost-effectiveness analysis was conducted using a Markov model from a health system\u2019s perspective over a 10-year time frame, incorporating a new birth cohort annually. Two vaccination scenarios were examined 1) a constant coverage improvement scenario, assuming current funding is maintained resulting in annual increases of 0.3% and 2% in the first and second-dose measles vaccine coverage, respectively, alongside supplementary immunization activities(SIAs) and 2) an intensified investment scenario, assuming achievement of 95% coverage for both vaccine doses in addition to SIAs. The later assumed increased investments to reach hard-to-reach populations. A threshold of USD 1,280 per disability adjusted life year (DALY) averted was applied. A budget impact analysis was also conducted. Over a 10-year time horizon, the constant coverage improvement scenario led to 6% fewer deaths (213 (161\u2013276)) and was cost-effective (incremental cost-effectiveness ratio, ICER\u2009=\u2009USD 1,269 ($1,205-$1,333) per DALY averted) compared to the base scenario. Increasing coverage in the intensified investment scenario, further reduced deaths by 25% (879(626--1,284)) and was more cost effective, ICER 1,093 (1,029 -1,157) per DALY averted, compared to the constant improvement scenario. The constant improvement scenario had a moderate budget impact while the intensified improvement scenario had a very high budget impact, when assessed against Kenya\u2019s health expenditure. Our findings suggest that accelerating measles coverage through intensified investments towards measles elimination is cost-effective but has a high budget impact. Therefore, policy makers should consider market shaping interventions and strategies to mobilize and allocate sufficient resources to increase vaccination coverage and ensure sustained health gains.<\/jats:p>","DOI":"10.1371\/journal.pgph.0006440","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:24:01Z","timestamp":1790097841000},"page":"e0006440","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness and budget impact analyses of strategies to improve measles vaccination coverage in Kenya"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3236-5229","authenticated-orcid":true,"given":"Stacey","family":"Orangi","sequence":"first","affiliation":[{"name":"KEMRI-Wellcome Trust Research Programme","place":["Nairobi, Kenya"],"department":["Health Economics Research Unit"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8249-746X","authenticated-orcid":true,"given":"Prashant","family":"Mandaliya","sequence":"additional","affiliation":[{"name":"KEMRI-Wellcome Trust Research Programme","place":["Nairobi, Kenya"],"department":["Health Economics Research Unit"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Jalang\u2019o","sequence":"additional","affiliation":[{"name":"Ministry of Health, Government of Kenya","place":["Nairobi, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Amoth","sequence":"additional","affiliation":[{"name":"Ministry of Health, Government of Kenya","place":["Nairobi, Kenya"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alick","family":"Banda","sequence":"additional","affiliation":[{"name":"University of Zambia","place":["Lusaka, Zambia"],"department":["Department of Economics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chibueze","family":"Anosike","sequence":"additional","affiliation":[{"name":"Health Policy Research Group, University of Nigeria","place":["Nsukka, Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Masiye","sequence":"additional","affiliation":[{"name":"University of Zambia","place":["Lusaka, Zambia"],"department":["Department of Economics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Obinna","family":"Onwujekwe","sequence":"additional","affiliation":[{"name":"Health Policy Research Group, University of Nigeria","place":["Nsukka, Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwine","family":"Barasa","sequence":"additional","affiliation":[{"name":"KEMRI-Wellcome Trust Research Programme","place":["Nairobi, Kenya"],"department":["Health Economics Research Unit"]},{"name":"Centre for Tropical Medicine and Global Health","place":["Oxford, United Kingdom"],"department":["Nuffield Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"pgph.0006440.ref001","doi-asserted-by":"crossref","first-page":"102502","DOI":"10.1016\/j.eclinm.2024.102502","article-title":"Concerning global rise in measles cases","volume":"68","author":"eClinicalMedicine","year":"2024","journal-title":"EClinicalMedicine"},{"key":"pgph.0006440.ref002","doi-asserted-by":"crossref","unstructured":"Minta A, Ferrari M, Antoni S, Lambert B, Sayi T, Hsu C, et al. Progress Toward Measles Elimination \u2014 Worldwide, 2000\u20132023. MMWR Morb Mortal Wkly Rep 2024. 2024(73):1036\u201342.","DOI":"10.15585\/mmwr.mm7345a4"},{"key":"pgph.0006440.ref003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.11604\/pamj.2018.31.65.16309","article-title":"Progress towards elimination of measles in Kenya, 2003-2016","volume":"31","author":"N Kisangau","year":"2018","journal-title":"The Pan African medical journal"},{"key":"pgph.0006440.ref004","unstructured":"World Health Organization. 16 million children protected in Kenya\u2019s measles, rubella and typhoid vaccination campaign 2025 [Available from: https:\/\/www.afro.who.int\/node\/22070"},{"issue":"1","key":"pgph.0006440.ref005","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1186\/s12913-020-05880-5","article-title":"The economic burden of measles in children under five in Bangladesh","volume":"20","author":"G de Broucker","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"pgph.0006440.ref006","doi-asserted-by":"crossref","first-page":"100077","DOI":"10.1016\/j.jvacx.2020.100077","article-title":"The economic burden of measles in children under five in Uganda","volume":"6","author":"G De Broucker","year":"2020","journal-title":"Vaccine X"},{"key":"pgph.0006440.ref007","unstructured":"World Health Organization. Measles vaccines: WHO position paper-April 2017. Weekly Epidemiological Record; 2017."},{"key":"pgph.0006440.ref008","unstructured":"World Health Organization. Measles Vaccination Coverage 2025 [Available from: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/measles-vaccination-coverage?CODE=Global&ANTIGEN=MCV1\u00b1MCV2&YEAR=."},{"key":"pgph.0006440.ref009","unstructured":"World Health Organization. Immunization Agenda 2030: A Global Strategy to Leave No One Behind. 2020."},{"key":"pgph.0006440.ref010","doi-asserted-by":"crossref","unstructured":"Masresha B, Hatcher C, Lebo E, Tanifum P, Bwaka A, Minta A, et al. Progress Toward Measles Elimination - African Region, 2017-2021. MMWR Morb Mortal Wkly Rep 2023. 2023(72):985\u201391.","DOI":"10.15585\/mmwr.mm7236a3"},{"key":"pgph.0006440.ref011","unstructured":"Ministry of Health Kenya. Kenya National Immunization Policy Guidelines. 2023."},{"issue":"34","key":"pgph.0006440.ref012","first-page":"678","article-title":"Centers for Disease Control and Prevention (CDC). Measles--Horn of Africa, 2010-2011","volume":"61","year":"2012","journal-title":"MMWR Morbidity and mortality weekly report"},{"issue":"37","key":"pgph.0006440.ref013","first-page":"969","article-title":"Centers for Disease Control and Prevention (CDC). Progress in measles control--Kenya 2002-2007","volume":"56","year":"2007","journal-title":"MMWR Morbidity and mortality weekly report"},{"key":"pgph.0006440.ref014","article-title":"An evaluation of the measles surveillance system, and descriptive epidemiology of measles in Kenya (2020 \u2013 2021)","author":"FM Ndonye","year":"2024","journal-title":"J Interv Epidemiol Public Health"},{"issue":"11","key":"pgph.0006440.ref015","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.vaccine.2009.06.035","article-title":"WHO Guide for standardisation of economic evaluations of immunization programmes","volume":"28","author":"DG Walker","year":"2010","journal-title":"Vaccine"},{"key":"pgph.0006440.ref016","unstructured":"Ministry of Health Kenya. Measles Vaccine Coverage Estimates for Kenya. 2024."},{"key":"pgph.0006440.ref017","unstructured":"World Health Organization. Global measles and rubella strategic plan: 2012-2020. 2012."},{"key":"pgph.0006440.ref018","unstructured":"World Health Organization. The Global Health Observatory-Measles-number of reported cases 2025 [Available from: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/measles---number-of-reported-cases"},{"key":"pgph.0006440.ref019","article-title":"Field effectiveness of live attenuated measles-containing vaccines: a review of published literature","author":"A Uzicanin","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"pgph.0006440.ref020","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(23)00043-8","article-title":"Estimating national-level measles case-fatality ratios in low-income and middle-income countries: an updated systematic review and modelling study","volume":"11","author":"AN Sbarra","year":"2023","journal-title":"Lancet Glob Health"},{"key":"pgph.0006440.ref021","volume-title":"Kenya Demographic and Health Survey 2022","author":"Kenya National Bureau of Statistics, ICF","year":"2023"},{"key":"pgph.0006440.ref022","unstructured":"UNICEF. Costs of Fully Vaccinating a Child: Countries Eligible for Gavi Vaccine Prices. 2024."},{"issue":"7","key":"pgph.0006440.ref023","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-011526","article-title":"Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries","volume":"8","author":"A Levin","year":"2023","journal-title":"BMJ Glob Health"},{"key":"pgph.0006440.ref024","unstructured":"Ministry of Health Kenya. Cost analysis of primary health care in Kenya. 2024."},{"key":"pgph.0006440.ref025","article-title":"Economic Burden of Measles among Hospitalised Children in Kenya","volume":"2026","author":"P Mandaliya","year":"2026","journal-title":"medRxiv: the preprint server for health sciences"},{"key":"pgph.0006440.ref026","volume-title":"Global Burden of Disease Study 2019 (GBD 2019) Disability Weights Seattle","author":"Global Burden of Disease Collaborative Network","year":"2020"},{"key":"pgph.0006440.ref027","unstructured":"World Bank Group. Life expectancy at birth, total (years) -Kenya 2024 [Available from: https:\/\/data.worldbank.org\/indicator\/SP.DYN.LE00.IN?locations=KE"},{"key":"pgph.0006440.ref028","unstructured":"Kenya National Bureau of Statistics. 2019 Kenya Population and Housing Census: Volume III: Distribution of Population by Age, Sex and Administrative Units. 2019."},{"issue":"3","key":"pgph.0006440.ref029","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/heapol\/16.3.326","article-title":"Calculating and presenting disability adjusted life years (DALYs) in cost-effectiveness analysis","volume":"16","author":"JA Fox-Rushby","year":"2001","journal-title":"Health Policy Plan"},{"issue":"6","key":"pgph.0006440.ref030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000964","article-title":"Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data","volume":"3","author":"J Ochalek","year":"2018","journal-title":"BMJ Glob Health"},{"issue":"8","key":"pgph.0006440.ref031","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research","volume":"19","author":"B Woods","year":"2016","journal-title":"Value in Health"},{"key":"pgph.0006440.ref032","unstructured":"International Monetrary Fund. GDP per capita, current prices (USD per capita) 2026 [Available from: https:\/\/www.imf.org\/external\/datamapper\/NGDPDPC@WEO\/KEN?zoom=KEN&highlight=KEN"},{"issue":"37","key":"pgph.0006440.ref033","first-page":"164","article-title":"Measures of the effect of vaccination in an outbreak of measles","volume":"7","author":"C Amela Heras","year":"1993","journal-title":"Gac Sanit"},{"issue":"12","key":"pgph.0006440.ref034","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(25)00319-5","article-title":"Affordability decision rules: a systematic review and framework for categorising budget impact thresholds across health systems","volume":"13","author":"A Pichon-Riviere","year":"2025","journal-title":"Lancet Glob Health"},{"key":"pgph.0006440.ref035","unstructured":"World Bank Group. Current health expenditure per capita (current US$) - Kenya. 2025."},{"issue":"10","key":"pgph.0006440.ref036","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(22)00335-7","article-title":"Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study","volume":"10","author":"AK Winter","year":"2022","journal-title":"Lancet Glob Health"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:24:09Z","timestamp":1790097849000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0006440"}},"subtitle":[],"editor":[{"given":"Julia","family":"Robinson","sequence":"first","affiliation":[{"name":"PLOS: Public Library of Science","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0006440","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]}}}